The most recent article in the list, authored by Fillatreau S, had a burst strength of 3.55, summarizing the role of TLR4 in AKI, highlighting that TLR4 exacerbated kidney damage by triggering an inflammatory response, and targeting TLR4 might be a potential strategy for AKI treatment (50). This evidence concerns the gene TLR4 and acute kidney injury.